Lin Ni
Private Equity Investor bei 6 Dimensions Capital
Aktive Positionen von Lin Ni
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Private Equity Investor | 18.05.2017 | - |
Karriereverlauf von Lin Ni
Ehemalige bekannte Positionen von Lin Ni
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 23.04.2021 | 29.07.2022 |
| Frontline Bioventures | Direktor/Vorstandsmitglied | - | 18.05.2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.03.2021 | - |
Ausbildung von Lin Ni
| Osaka University | Doctorate Degree |
Statistik
International
| China | 5 |
| Japan | 2 |
Operativ
| Director/Board Member | 3 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sektoral
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Frontline Bioventures | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
